Tag Archives: primary care

Not long ago, diabetes management focused primarily on controlling blood glucose levels. Today, that approach has evolved dramatically as cardiologists and endocrinologists increasingly work together to reduce cardiovascular risk. Thanks to groundbreaking cardiovascular outcome trials (CVOTs), clinicians now understand that treating type 2 diabetes means protecting the heart, kidneys, and …

As demand for GLP-1 receptor agonists continues to outpace supply, many patients have turned to compounded medications obtained through telehealth companies, medical spas, wellness clinics, and compounding pharmacies. While these products may improve access for some individuals, they also introduce important clinical, regulatory, and medicolegal challenges. Providers increasingly encounter patients …

Postpartum screening after gestational diabetes is one of the most important yet overlooked steps in preventing future type 2 diabetes. Although blood glucose levels often return to normal after delivery, the long-term metabolic risk does not disappear. In fact, up to half of individuals diagnosed with gestational diabetes mellitus (GDM) …

Blood pressure control remains one of the most powerful tools for reducing cardiovascular and kidney complications in people with diabetes. While clinicians have traditionally focused on achieving targets below 140/90 mmHg, recent evidence and the 2026 American Diabetes Association Standards of Care support a more intensive approach for selected high-risk …

Patients treated with corticosteroids for asthma, COPD exacerbations, rheumatologic disease, inflammatory bowel disease, or cancer-related complications often develop significant elevations in blood glucose. In many cases, these patients have no prior history of diabetes. Yet within days of therapy initiation, blood glucose levels can rise dramatically, creating a challenging clinical …

A patient starts semaglutide through a telehealth platform, receives nutrition advice from a wellness clinic, and later visits a primary care physician for worsening gastrointestinal symptoms. None of the providers can see the full treatment picture. Situations like this are becoming increasingly common as GLP-1 medications move across multiple corners …

For many patients, antipsychotic medications are life-changing, even life-saving. Yet the same treatments that stabilize mood and thought can quietly drive weight gain, insulin resistance, and rising cardiometabolic risk. Over time, this unintended consequence places patients with serious mental illness at a much higher risk for obesity, type 2 diabetes, …

Prediabetes affects a striking proportion of adults worldwide, creating a crucial window for intervention before type 2 diabetes develops. While medications like metformin are frequently considered for high-risk individuals, evidence from large clinical trials shows that lifestyle-based strategies — especially the National Diabetes Prevention Program — can dramatically reduce the …